Hatch-Waxman Act Proposed Legislative Changes Affecting Pharmaceutical Patents

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service

Language:

English

Subjects (All):

Drugs.

Patents.

Physical Description:

1 online resource

Contained In:

ProQuest U.S. Congressional Research Digital Collection

Place of Publication:

[Washington, D.C.] [publisher not identified] 2003

Summary:

Reviews proposed legislative changes to the Drug Price Competition and Patent Term Restoration Act of 1984, known as the Hatch-Waxman Act, which revised patent laws as applied to pharmaceutical products. Discusses general provisions of the law, selected patent-related issues, FTC report on abbreviated new drug applications, FDA rule change regarding requirements for listing pharmaceutical patents in the Orange Book, and various legislative proposals in the 108th Congress to amend the Hatch-Waxman Act

Notes:

CRS Report

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC

Vendor supplied data

Other Format:

Microfiche version Library of Congress. Congressional Research Service. Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Publisher Number:

CRS-2003-RSI-0243

Access Restriction:

Restricted for use by site license